Saturday, April 27, 2024
Advertisement
  • watson sends patent challenge notice to ranbaxy

    Watson sends patent challenge notice to Ranbaxy

    Sep 20, 2013, 05:12 PM IST

    New Delhi: Drug firm Ranbaxy Laboratories has said its US arm has received a notice from Watson Laboratories Inc, challenging the patent of acne treatment drug Absorica.The drug is licensed to Ranbaxy Laboratories from Cipher

Advertisement
Advertisement
Advertisement
Advertisement